Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.

The identification of susceptibility genes for human disease is a major goal of current biomedical research. Both sequence and structural variation have emerged as major genetic sources of phenotypic variability and growing evidence points to copy number variation as a particularly important source...

Full description

Bibliographic Details
Main Authors: Ermakova, O, Piszczek, L, Luciani, L, Cavalli, F, Ferreira, T, Farley, D, Rizzo, S, Paolicelli, R, Al-Banchaabouchi, M, Nerlov, C, Moriggl, R, Luscombe, N, Gross, C
Format: Journal article
Language:English
Published: 2011
_version_ 1826297527488479232
author Ermakova, O
Piszczek, L
Luciani, L
Cavalli, F
Ferreira, T
Farley, D
Rizzo, S
Paolicelli, R
Al-Banchaabouchi, M
Nerlov, C
Moriggl, R
Luscombe, N
Gross, C
author_facet Ermakova, O
Piszczek, L
Luciani, L
Cavalli, F
Ferreira, T
Farley, D
Rizzo, S
Paolicelli, R
Al-Banchaabouchi, M
Nerlov, C
Moriggl, R
Luscombe, N
Gross, C
author_sort Ermakova, O
collection OXFORD
description The identification of susceptibility genes for human disease is a major goal of current biomedical research. Both sequence and structural variation have emerged as major genetic sources of phenotypic variability and growing evidence points to copy number variation as a particularly important source of susceptibility for disease. Here we propose and validate a strategy to identify genes in which changes in dosage alter susceptibility to disease-relevant phenotypes in the mouse. Our approach relies on sensitized phenotypic screening of megabase-sized chromosomal deletion and deficiency lines carrying altered copy numbers of ∼30 linked genes. This approach offers several advantages as a method to systematically identify genes involved in disease susceptibility. To examine the feasibility of such a screen, we performed sensitized phenotyping in five therapeutic areas (metabolic syndrome, immune dysfunction, atherosclerosis, cancer and behaviour) of a 0.8 Mb reciprocal chromosomal duplication and deficiency on chromosome 11 containing 27 genes. Gene dosage in the region significantly affected risk for high-fat diet-induced metabolic syndrome, antigen-induced immune hypersensitivity, ApoE-induced atherosclerosis, and home cage activity. Follow up studies on individual gene knockouts for two candidates in the region showed that copy number variation in Stat5 was responsible for the phenotypic variation in antigen-induced immune hypersensitivity and metabolic syndrome. These data demonstrate the power of sensitized phenotypic screening of segmental aneuploidy lines to identify disease susceptibility genes.
first_indexed 2024-03-07T04:33:00Z
format Journal article
id oxford-uuid:cef62abe-d8f6-4658-b7ba-af43d8f1afba
institution University of Oxford
language English
last_indexed 2024-03-07T04:33:00Z
publishDate 2011
record_format dspace
spelling oxford-uuid:cef62abe-d8f6-4658-b7ba-af43d8f1afba2022-03-27T07:39:10ZSensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cef62abe-d8f6-4658-b7ba-af43d8f1afbaEnglishSymplectic Elements at Oxford2011Ermakova, OPiszczek, LLuciani, LCavalli, FFerreira, TFarley, DRizzo, SPaolicelli, RAl-Banchaabouchi, MNerlov, CMoriggl, RLuscombe, NGross, CThe identification of susceptibility genes for human disease is a major goal of current biomedical research. Both sequence and structural variation have emerged as major genetic sources of phenotypic variability and growing evidence points to copy number variation as a particularly important source of susceptibility for disease. Here we propose and validate a strategy to identify genes in which changes in dosage alter susceptibility to disease-relevant phenotypes in the mouse. Our approach relies on sensitized phenotypic screening of megabase-sized chromosomal deletion and deficiency lines carrying altered copy numbers of ∼30 linked genes. This approach offers several advantages as a method to systematically identify genes involved in disease susceptibility. To examine the feasibility of such a screen, we performed sensitized phenotyping in five therapeutic areas (metabolic syndrome, immune dysfunction, atherosclerosis, cancer and behaviour) of a 0.8 Mb reciprocal chromosomal duplication and deficiency on chromosome 11 containing 27 genes. Gene dosage in the region significantly affected risk for high-fat diet-induced metabolic syndrome, antigen-induced immune hypersensitivity, ApoE-induced atherosclerosis, and home cage activity. Follow up studies on individual gene knockouts for two candidates in the region showed that copy number variation in Stat5 was responsible for the phenotypic variation in antigen-induced immune hypersensitivity and metabolic syndrome. These data demonstrate the power of sensitized phenotypic screening of segmental aneuploidy lines to identify disease susceptibility genes.
spellingShingle Ermakova, O
Piszczek, L
Luciani, L
Cavalli, F
Ferreira, T
Farley, D
Rizzo, S
Paolicelli, R
Al-Banchaabouchi, M
Nerlov, C
Moriggl, R
Luscombe, N
Gross, C
Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.
title Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.
title_full Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.
title_fullStr Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.
title_full_unstemmed Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.
title_short Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.
title_sort sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice
work_keys_str_mv AT ermakovao sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT piszczekl sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT lucianil sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT cavallif sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT ferreirat sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT farleyd sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT rizzos sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT paolicellir sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT albanchaabouchim sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT nerlovc sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT morigglr sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT luscomben sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice
AT grossc sensitizedphenotypicscreeningidentifiesgenedosagesensitiveregiononchromosome11thatpredisposestodiseaseinmice